glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with 2-amino-5-phosphonovalerate in 3 studies
| Studies (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Trials (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Studies (2-amino-5-phosphonovalerate) | Trials (2-amino-5-phosphonovalerate) | Recent Studies (post-2010) (2-amino-5-phosphonovalerate) |
|---|---|---|---|---|---|
| 162 | 1 | 20 | 4,393 | 1 | 539 |
| Protein | Taxonomy | glycyl-arginyl-glycyl-aspartyl-seryl-proline (IC50) | 2-amino-5-phosphonovalerate (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Gall, CM; Lynch, G; Zhou, J | 1 |
| Kramár, EA; Lynch, G | 1 |
| Bernard-Trifilo, JA; Gall, CM; Kramár, EA; Lin, CY; Lynch, G; Pineda, EA; Torp, R | 1 |
3 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and 2-amino-5-phosphonovalerate
| Article | Year |
|---|---|
Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists.
Topics: 2-Amino-5-phosphonovalerate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cathepsin D; Culture Techniques; Hippocampus; Immunohistochemistry; Integrins; Microglia; Oligopeptides; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2002 |
Developmental and regional differences in the consolidation of long-term potentiation.
Topics: Animals; Animals, Newborn; Antibodies, Monoclonal; Dendrites; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Integrin alpha Chains; Long-Term Potentiation; Male; Neural Pathways; Oligopeptides; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors; Valine | 2003 |
Integrin signaling cascades are operational in adult hippocampal synapses and modulate NMDA receptor physiology.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Blotting, Western; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Focal Adhesion Protein-Tyrosine Kinases; Hippocampus; In Vitro Techniques; Integrins; Male; Microscopy, Electron, Transmission; Neurons; Oligopeptides; Oligoribonucleotides, Antisense; Patch-Clamp Techniques; Phosphorylation; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction; src-Family Kinases; Synapses; Synaptosomes; Time Factors; Valine | 2005 |